A commentary on 'Toxicities associated with immune checkpoint inhibitors: a systematic study'

Int J Surg. 2024 Jan 1;110(1):574-575. doi: 10.1097/JS9.0000000000000718.

Authors

Yuan Liu¹, Letian Qiao¹, Han Liu²

Affiliations

¹ Department of Pharmacy, First People's Hospital of Shangqiu, Henan.
² Chinese Preventive Medicine Association, Beijing, People's Republic of China.

No abstract available

MeSH terms

Humans
Immune Checkpoint Inhibitors* / adverse effects
Neoplasms*
Programmed Cell Death 1 Receptor

Substances

Immune Checkpoint Inhibitors
Programmed Cell Death 1 Receptor